Pharmacokinetic Considerations in Amputees.
Elbarbry F, Nguyen V, Kawaguchi-Suzuki M.
J Pharm Pract. 2021 Oct;34(5):794-799. doi: 10.1177/0897190020942659. Epub 2020 Jul 29.
Influence of the microbiota and probiotics in obesity.
Fontané L, Benaiges D, Goday A, Llauradó G, Pedro-Botet J.
Clin Investig Arterioscler. 2018 Nov-Dec;30(6):271-279. doi: 10.1016/j.arteri.2018.03.004. Epub 2018 May 25.
Activity-balanced GLP-1/GDF15 dual agonist reduces body weight and metabolic disorder in mice and non-human primates.
Zhang Y, Zhao X, Dong X, Zhang Y, Zou H, Jin Y, Guo W, Zhai P, Chen X, Kharitonenkov A.
Cell Metab. 2023 Feb 7;35(2):287-298.e4. doi: 10.1016/j.cmet.2023.01.001. Epub 2023 Jan 26.
Discovery, development, and clinical proof of mechanism of LY3463251, a long-acting GDF15 receptor agonist.
Benichou O, Coskun T, Gonciarz MD, Garhyan P, Adams AC, Du Y, Dunbar JD, Martin JA, Mather KJ, Pickard RT, Reynolds VL, Robins DA, Zvada SP, Emmerson PJ.
Cell Metab. 2023 Feb 7;35(2):274-286.e10. doi: 10.1016/j.cmet.2022.12.011. Epub 2023 Jan 10.
Sugar-sweetened beverage consumption and weight gain in children and adults: a systematic review and meta-analysis of prospective cohort studies and randomized controlled trials.
Nguyen M, Jarvis SE, Tinajero MG, Yu J, Chiavaroli L, Mejia SB, Khan TA, Tobias DK, Willett WC, Hu FB, Hanley AJ, Birken CS, Sievenpiper JL, Malik VS.
Am J Clin Nutr. 2023 Jan;117(1):160-174. doi: 10.1016/j.ajcnut.2022.11.008. Epub 2022 Dec 20.
Anesthetizing the obese.
Green B, McLeay SC.
Anesth Analg. 2011 Jul;113(1):1-3. doi: 10.1213/ANE.0b013e318212eae8.
Associations of obesity indices change with cardiovascular outcomes: a dose-response meta-analysis.
Wang L, Ding H, Deng Y, Huang J, Lao X, Wong MCS.
Int J Obes (Lond). 2024 May;48(5):635-645. doi: 10.1038/s41366-024-01485-8. Epub 2024 Feb 9.
Pediatric Obesity: Pharmacokinetic Alterations and Effects on Antimicrobial Dosing.
Natale S, Bradley J, Nguyen WH, Tran T, Ny P, La K, Vivian E, Le J.
Pharmacotherapy. 2017 Mar;37(3):361-378. doi: 10.1002/phar.1899. Epub 2017 Feb 27.
Body weight time in target range and cardiovascular outcomes in adults with overweight/obesity and type 2 diabetes.
Liu M, Xu X, Chen X, Guo Y, Zhang S, Lin Y, Zhou H, Li M, Xie P, Xia W, Wang L, Zhuang X, Liao X.
Eur J Prev Cardiol. 2023 Sep 6;30(12):1263-1271. doi: 10.1093/eurjpc/zwad165.
A role of low dose chemical mixtures in adipose tissue in carcinogenesis.
Lee DH, Jacobs DR Jr, Park HY, Carpenter DO.
Environ Int. 2017 Nov;108:170-175. doi: 10.1016/j.envint.2017.08.015. Epub 2017 Aug 31.
